Cargando...
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused by the severe acute respiratory syndrome (SARS)‐coronavirus 2(CoV‐2) coronavirus is hampered by the lack of knowledge concerning the basic cell biology of the infection. Given that most viruses use endocytosis to...
Gardado en:
| Publicado en: | FEBS J |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276759/ https://ncbi.nlm.nih.gov/pubmed/32428379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15369 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|